Antibodies against a secreted product of Staphylococcus aureus trigger phagocytic killing

Journal of Experimental Medicine

Volumn 213, Issue 3, 2016, Pages 293-301

  Thomer, Lena ^a   Emolo, Carla ^a   Thammavongsa, Vilasack ^a   Kim, Hwan Keun ^a   McAdow, Molly E ^a   Yu, Wenqi ^a   Kieffer, Matthew ^a   Schneewind, Olaf ^a   Missiakas, Dominique ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COAGULASE; FIBRIN; FIBRINOGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3B3; MONOCLONAL ANTIBODY 5D5; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; OPSONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; COAGULASE POSITIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; AMINO ACID REPEAT; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; IMMUNOLOGY; METABOLISM; PROTEIN TERTIARY STRUCTURE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

AGGLUTINATION; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; COAGULASE; FEMALE; FIBRIN; HUMANS; MICE, INBRED BALB C; OPSONIN PROTEINS; PHAGOCYTOSIS; PROTEIN STRUCTURE, TERTIARY; REPETITIVE SEQUENCES, AMINO ACID; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84961221461     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20150074     Document Type: Article

References (26)

1. Bae, T., and O. Schneewind. 2006. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid. 55:58-63. http://dx.doi.org/10.1016/j.plasmid.2005.05.005
2. Bjerketorp, J., K. Jacobsson, and L. Frykberg. 2004. The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase. FEMS Microbiol. Lett. 234:309-314. http://dx.doi.org/10.1111/j.1574-6968.2004.tb09549.x
3. Cheng, A.G., M. McAdow, H.K. Kim, T. Bae, D.M. Missiakas, and O. Schneewind. 2010. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog. 6:e1001036. http://dx.doi.org/10.1371/journal.ppat.1001036
4. David, M.Z., and R.S. Daum. 2010. Community-associated methicillinresistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23:616-687. http://dx.doi.org/10.1128/CMR.00081-09
5. Fowler, V.G., K.B. Allen, E.D. Moreira, M. Moustafa, F. Isgro, H.W. Boucher, G.R. Corey, Y. Carmeli, R. Betts, J.S. Hartzel, et al. 2013. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA. 309:1368-1378. http://dx.doi.org/10.1001/jama.2013.3010
6. Friedrich, R., P. Panizzi, P. Fuentes-Prior, K. Richter, I. Verhamme, P.J. Anderson, S. Kawabata, R. Huber, W. Bode, and P.E. Bock. 2003. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature. 425:535-539. http://dx.doi.org/10.1038/nature01962
7. Guggenberger, C., C. Wolz, J.A. Morrissey, and J. Heesemann. 2012. Two distinct coagulase-dependent barriers protect Staphylococcus aureus from neutrophils in a three dimensional in vitro infection model. PLoS Pathog. 8:e1002434. http://dx.doi.org/10.1371/journal.ppat.1002434
8. Kroh, H.K., P. Panizzi, and P.E. Bock. 2009. Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proc. Natl. Acad. Sci. USA. 106:7786-7791. http://dx.doi.org/10.1073/pnas.0811750106
9. McAdow, M., H.K. Kim, A.C. Dedent, A.P.A. Hendrickx, O. Schneewind, and D.M. Missiakas. 2011. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog. 7:e1002307. http://dx.doi.org/10.1371/journal.ppat.1002307
10. McAdow, M., A.C. DeDent, C. Emolo, A.G. Cheng, B.N. Kreiswirth, D.M. Missiakas, and O. Schneewind. 2012a. Coagulases as determinants of protective immune responses against Staphylococcus aureus. Infect. Immun. 80:3389-3398. http://dx.doi.org/10.1128/IAI.00562-12
11. McAdow, M., D.M. Missiakas, and O. Schneewind. 2012b. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections. J. Innate Immun. 4:141-148. http://dx.doi.org/10.1159/000333447
12. McDevitt, D., P. Francois, P. Vaudaux, and T.J. Foster. 1994. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol. Microbiol. 11:237-248. http://dx.doi.org/10.1111/j.1365-2958.1994.tb00304.x
13. Mimura, N., and A. Asano. 1976. Synergistic effect of colchicine and cytochalasin D on phagocytosis by peritoneal macrophages. Nature. 261:319-321. http://dx.doi.org/10.1038/261319a0
14. Nanra, J.S., S.M. Buitrago, S. Crawford, J. Ng, P.S. Fink, J. Hawkins, I.L. Scully, L.K. McNeil, J.M. Aste-Amézaga, D. Cooper, et al. 2013. Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Hum. Vaccin. Immunother. 9:480-487. http://dx.doi.org/10.4161/hv.23223
15. Panizzi, P., R. Friedrich, P. Fuentes-Prior, W. Bode, and P.E. Bock. 2004. The staphylocoagulase family of zymogen activator and adhesion proteins. Cell. Mol. Life Sci. 61:2793-2798. http://dx.doi.org/10.1007/s00018-004-4285-7
16. Panizzi, P., M. Nahrendorf, J.L. Figueiredo, J. Panizzi, B. Marinelli, Y. Iwamoto, E. Keliher, A.A. Maddur, P. Waterman, H.K. Kroh, et al. 2011. In vivo detection of Staphylococcus aureus endocarditis by targeting pathogenspecific prothrombin activation. Nat. Med. 17:1142-1146. http://dx.doi.org/10.1038/nm.2423
17. Rammelkamp, C.H., M.M. Hezebicks, and J.H. Dingle. 1950. Specific coagulases of Staphylococcus aureus. J. Exp. Med. 91:295-307. http://dx.doi.org/10.1084/jem.91.3.295
18. Robbins, J.B., R. Schneerson, and S.C. Szu. 1996. Hypothesis: how licensed vaccines confer protective immunity. Adv. Exp. Med. Biol. 397:169-182. http://dx.doi.org/10.1007/978-1-4899-1382-1_22
19. Shinefield, H., S. Black, A. Fattom, G. Horwith, S. Rasgon, J. Ordonez, H. Yeoh, D. Law, J.B. Robbins, R. Schneerson, et al. 2002. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N. Engl. J. Med. 346:491-496. http://dx.doi.org/10.1056/NEJMoa011297
20. Smith, W., J.H. Hale, and M.M. Smith. 1947. The role of coagulase in staphylococcal infections. Br. J. Exp. Pathol. 28:57-67.
21. Spaan, A.N., B.G.J. Surewaard, R. Nijland, and J.A.G. van Strijp. 2013. Neutrophils versus Staphylococcus aureus: a biological tug of war. Annu. Rev. Microbiol. 67:629-650. http://dx.doi.org/10.1146/annurev-micro-092412-155746
22. Spellberg, B., and R. Daum. 2012. Development of a vaccine against Staphylococcus aureus. Semin. Immunopathol. 34:335-348. http://dx.doi.org/10.1007/s00281-011-0293-5
23. Tager, M. 1956. Studies on the nature and the purification of the coagulasereacting factor and its relation to prothrombin. J. Exp. Med. 104:675-686. http://dx.doi.org/10.1084/jem.104.5.675
24. Thammavongsa, V., D.M. Missiakas, and O. Schneewind. 2013. Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science. 342:863-866. http://dx.doi.org/10.1126/science.1242255
25. Thomer, L., O. Schneewind, and D. Missiakas. 2013. Multiple ligands of von Willebrand factor-binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma. J. Biol. Chem. 288:28283-28292. http://dx.doi.org/10.1074/jbc.M113.493122
26. Watanabe, S., T. Ito, T. Sasaki, S. Li, I. Uchiyama, K. Kishii, K. Kikuchi, R.L. Skov, and K. Hiramatsu. 2009. Genetic diversity of staphylocoagulase genes (coa): insight into the evolution of variable chromosomal virulence factors in Staphylococcus aureus. PLoS One. 4:e5714. http://dx.doi.org/10.1371/journal.pone.0005714